Phase Ib/II Trial Of Pembrolizumab (MK-3475) Combination Therapies In Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Read more
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Clinical Trial To Study The Efficacy And Safety Of Pembrolizumab (MK-3475) In Combination With Chemoradiotherapy (CRT) Versus CRT Alone In Participants With Muscle-Invasive Bladder Cancer (MIBC) (KEYNOTE-992) Read more
A Phase Ib/Ii,Open-Label, Multicenter, Randomized Umbrella Study Evaluating The Efficacy And Safety Of Multiple Immunotherapy-Based Treatment Combinations In Patients With Metastatic Triple-Negative Breast Cancer (Morpheus-Tnbc) Read more
A Prospective Multi-Site Single- Arm Phase II Study To Investigate Breast IORT – The Efficacy Of Single-Fraction Intraoperative Radiation Treatment Using A Multi-Lumen Balloon Applicator And In-Room CT Imaging For The Treatment Of Early-Stage Breast Cancer. Read more
OXEL: A Pilot Study Of Immune Checkpoint Or Capecitabine Or Combination Therapy As Adjuvant Therapy For Triple Negative Breast Cancer With Residual Disease Following Neoadjuvant Chemotherapy Read more
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study Of Nivolumabversus Placebo In Combination With Neoadjuvant Chemotherapy And Adjuvant Endocrine Therapy In Patients With High-Risk, Estrogen Receptor-Positive (ER+), Human Epidermalgrowth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer Read more
